JPRN-UMIN000029194已完成未知
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetes - EMPYREAN study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients treated with insulin or GLP-1 analogue 2) Patients with eGFR<45mL/min/1.73m2 3) Patients with Afib 4) Patients implanted PM 5) Patients who treated with beta-blockers, alpha-blokers, Digoxis, and CCB.
研究者
相似试验
招募中
3 期
The effect of Empagliflozin on outcomes of patients with myocardial infarction undergoing primary PCIIRCT20220809055645N7Rasht University of Medical Sciences54
尚未招募
3 期
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
已完成
Unknown
Evaluation of the effect of empagliflozin in combination with pioglitazone on fatty liver diseaseFatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20240208060939N1Artesh University of Medical Sciences80
已完成
1 期
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30
招募中
2 期
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart surgeryAtrial fibrillation after heart surgery.Paroxysmal atrial fibrillationIRCT20120520009801N9Mashhad University of Medical Sciences160